Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Professor Raph L Hamers

Professor Raph L Hamers

Podcast interview

Developing collaborative clinical trials in Indonesia

Indonesia is a very populous country with a huge burden of infectious diseases such as TB, malaria, HIV and CNS infections. Running clinical trials requires high levels of expertise, currently developed and strengthened by institutions such as IOCRL (Universities of Indonesia and Oxford Clinical Research laboratory). Better collaborations will also help great ideas make a bigger impact.

View podcast transcript

Social media

Raph Hamers


Associate Professor

  • Associate Professor, Nuffield Dept of Medicine, University of Oxford
  • Clinical Infectious Diseases Research Programme Leader, EOCRU Jakarta
  • Manager of the Universities of Indonesia and Oxford Clinical Research Laboratory (IOCRL)
  • Internist and infectious disease physician

Eijkman Oxford Clinical Research Unit (EOCRU)

Raph Hamers, MD PhD, leads the clinical infectious disease research programme at the the Eijkman- Oxford Clinical Research Unit in Jakarta, Indonesia, and is an Associate Professor at University of Oxford. He is also an honorary consultant internist and infectious disease physician at the Amsterdam University Medical Centres and an honorary research fellow at the Faculty of Medicine University of Indonesia (FKUI).

He earned a PhD in Medicine from the University of Amsterdam, and is a recipient of a Veni postdoc fellowship through the Dutch Research Council (NWO) Talent Programme. His research work spans from biomedicine to global health, with a focus on improving health outcomes of complex infectious diseases in low and middle income countries. 

Dr. Hamers has extensive experience as a lead investigator of clinical trials and connected epidemiological, social and laboratory science in sub-Saharan Africa and Southeast Asia, with a focus on the diagnosis and clinical management, drug resistance and immune function in HIV-1 infection, the clinical management of tuberculosis, antimicrobial stewardship interventions, and emerging infectious diseases. His research since 2020 includes a substantive COVID-19 research portfolio on diagnostics for SARS-CoV-2 infection, assessment of COVID-19 vaccines and therapeutics, and impact of COVID-19 on the wider health system.

In 2018, Dr. Hamers established the Clinical Infectious Disease Research Programme, embedded in the Universities of Indonesia-Oxford Clinical Research Laboratory (IOCRL) on the FKUI premises in Jakarta, a facility that serves as a clinical trials unit and hub for research training and public and community engagement with science in Indonesia. His work emphasizes strengthening local research capacity and developing a broader collaborative clinical research agenda in Indonesia, with EOCRU's principal partners and the Oxford Tropical Network. 


Recent publications

More publications